Snowball logo
logo
INSM_logo

Insmed Incorporated

INSM β€’ NASDAQ
$126.33-$5.95Β  (4.5%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
188.5245.4305.2363.7606.41,137.6
COGS
44.1555.1365.5785.74124.9190.3
Gross Profit
144.3190.2239.6278481.5947.3
Operating Expenses & Income
Operating Income
(375.1)(457.3)(709.6)(878.3)(1,176.7)(817.5)
Total Operating Expenses
519.4647.6949.31,156.21,658.31,764.9
R&D Expenses
272.7397.5571598.4771.1860.8
Selling General & Admin Expenses
234.3265.8344.5461.1701.2893.6
Earnings from Continuing Operations
Interest Expense
(40.47)(26.45)(81.69)(84.91)(83.8)(81.34)
Interest Income
--1.8822.229--
Income Tax Expense
(1.758)1.3832.5553.7075.0266.205
Net Income
Net Income
(434.7)(481.5)(749.6)(913.8)(1,276.8)(875.3)
Supplemental
EBIT
(397.8)(457.7)(670.8)(829.8)(1,188)(790.5)
EBITDA
(383.6)(447.4)(660.2)(818.8)(1,171.5)(770)
In millions of USD, except % and values per 1 share